Virus Genome Detection – Adenoviruses
[Virusgenom-Nachweis – Adenoviren]
EPTIS factsheet 159516 | Last revision 2019-03-12 | URL: https://www.eptis.bam.de/pts159516 https://www.eptis.bam.de/pts159516
PT provider | |||||||
PT provider | INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories | ||||||
Based in | Germany | ||||||
Language(s) | German, English | ||||||
Remarks | Please fill in page 2 of the order form for handling of infectious samples for EQAS unless you already returned your completed form 2 to INSTAND e. V. when you registered for recent EQA schemes. Without your confirmation we cannot send you the EQAS samples. The INSTAND EQA schemes in virology are carried out in scientific cooperation with the Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten (DVV e.V.), Gesellschaft für Virologie (GfV e.V.) and Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM e.V.). Cooperation partners are: Joint Diagnostic Commission of DVV and GfV, Robert Koch-Institut, Paul-Ehrlich-Institut, Friedrich-Loeffler-Institut, Bernhard-Nocht-Institut, Reference Laboratories incl. National and International Reference Centers and National Consiliary Laboratories, Blood Transfusion Service of German Red Cross (DRK-Blutspendedienst Ost), World Health Organization and International Consortium for Blood Safety. The characterization of the EQA samples including the determination of the target values/consensus values is carried out in cooperation with the INSTAND Expert laboratories. EQA results can only be submitted online! General remarks on the INSTAND EQA schemes in virus diagnostics: Please note that the samples of the respective EQA schemes are suitable to be analyzed by different methods for the detection of the corresponding analyte. Example: EQA scheme “Virus immunology - HIV-1 / HIV-2“ - The 4 samples of the sample set of the EQA scheme (335) can be analyzed on virus specific antibodies by different methods such as ELISA, ChLIA and other methods. The results of the respective method should be stated for all 4 samples of the sample set. The results reported for the different methods will be displayed in the participation documents (Individual results). | ||||||
Keywords | |||||||
Product groups |
Human test material
|
||||||
Testing fields |
Medical analysis
|
||||||
Technical details | |||||||
|
|||||||
Aims of the PT scheme | |||||||
Target group of participants | |||||||
Linked to specific legislation / standards | |||||||
Additional, subsidiary aims | |||||||
Number of participants | 100 - 250 | ||||||
Accredited or otherwise reviewed by a 3rd party |
Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043 |
||||||
Operation is commissioned / requested by | German Bundesärztekammer (General medical Council) | ||||||
Fees and frequency | |||||||
Participation fee | 206 Euro / Survey | ||||||
Regularly operated | Yes (2 times per year) | ||||||
Year of first operation | Experience with operation of ILCs since 1968 | ||||||
Contact details of the PT provider | |||||||
Provider | Contact person | ||||||
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20 40223 Düsseldorf Germany Phone: +49-211-159213-0 Fax: +49-211-159213-30 Web: http://www.instandev.de/ http://www.instandev.de/ |
Dr. rer. nat. Nathalie Wojtalewicz
Phone: +49-211-15921341 Fax: +49-211-15921330 Email: wojtalewicz@instand-ev.de wojtalewicz@instand-ev.de |